Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism

NANot yet recruitingINTERVENTIONAL
Enrollment

2,972

Participants

Timeline

Start Date

October 8, 2025

Primary Completion Date

October 31, 2026

Study Completion Date

October 31, 2026

Conditions
Venous ThromboembolismPulmonary ThromboembolismsDigital Health
Interventions
OTHER

mobile venous thromboembolism application (mVTEA)

mVTEA will assist in the management of patients during the post-hospitalization follow-up phase. The mVTEA's doctor terminal automatically sends venous thromboembolism (VTE)-related health education materials in different frequencies and contents based on the patient's knowledge of VTE prevention and treatment, as well as their risk of thrombosis and bleeding during follow-up. In addition, thrombosis physicians on the mVTEA's doctor terminal can deliver health education to patients based on their condition. This can be done through the mVTEA doctor-patient communication module, which includes text, voice, and video communication.

Trial Locations (1)

100048

Sixth Medical Center of Chinese PLA General Hospital, Beijing

All Listed Sponsors
lead

Navy General Hospital, Beijing

OTHER

NCT06382038 - Smart Technology Facilitated Patient-centered Care for Patients With Pulmonary Thromboembolism | Biotech Hunter | Biotech Hunter